tag monoclonal-antibody-treatment 
PharmaShots
JANUARY 27, 2023
Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)
pharmaphorum
JANUARY 18, 2022
Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 23, 2022
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Oral therapy data presented at ASH. CellCentric, a U.K-based
The Checkup by Singlecare
JANUARY 15, 2023
The treatment of Alzheimer’s disease is garnering more attention and capturing headlines as the prevalence of dementia in older adults climbs. One of the longest-standing treatments, donepezil , is still a common first-line prescription for a disease marked by memory loss and functional decline. Compare donepezil alternatives.
European Pharmaceutical Review
DECEMBER 27, 2023
Product distribution requires shipping of apheresis starter materials, either cryopreserved or fresh (depending on the product), to the manufacturing site as well as shipping of final cryopreserved products to treatment centres. This is in addition to its considerable price tag. 6-8 Clinical recommendations also change.
Expert insights. Personalized for you.
40 
Let's personalize your content